Thermo Fisher Scientific Acquires Logistics Provider to Strengthen Clinical Trials Management Services |
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA, 02454
USA
Press release date: October 3, 2007
WALTHAM, Mass., Oct. 3 /-- Thermo Fisher Scientific Inc. today announced that it has acquired Priority Solutions International, a leading third-party logistics provider to the pharmaceutical and healthcare industries, following anti-trust clearance. Priority Solutions was previously majority-owned by Arsenal Capital Partners. With revenues of approximately $95 million in 2006, Priority Solutions offers a comprehensive range of services for the delivery of FDA-regulated pharmaceuticals, including shipment of pharmaceutical samples, direct-to-physician patient supplies, and pharmaceutical warehousing and order fulfillment.
Priority Solutions will be integrated into Thermo Fisher's biopharma services business, which includes the packaging and delivery of tightly regulated pharmaceutical samples to patients participating in clinical trials.
"The addition of Priority Solutions will make our biopharma services business an even stronger partner for biotechnology and pharmaceutical customers who are increasingly looking to outsource clinical trials management," said Marijn E. Dekkers, president and chief executive officer of Thermo Fisher Scientific. "This acquisition brings tremendous logistics expertise and an infrastructure to our existing outsourcing services that strengthens our ability to deliver pharmaceutical supplies to the right people at the right time - anywhere in the world."
Based in Swedesboro, New Jersey, Priority Solutions' non-asset-based logistics network extends to more than 500 cities worldwide. From order entry to final delivery, Priority Solutions tracks, manages and reports shipment status through call center specialists and a variety of Web-based tools available to both vendors and clients. Throughout the process, each step is fully documented to ensure end-to-end integrity of shipments in the highly regulated pharmaceutical and healthcare industries.
About Thermo Fisher Scientific
Thermo Fisher Scientific (NYSE:TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With an annual revenue rate of more than $9 billion, we employ 30,000 people and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit www.thermofisher.com.
FCMN Contact: investorrelations@thermo.com
Source: Thermo Fisher Scientific Inc.
CONTACT: Media, Lori Gorski, +1-781-622-1242, lori.gorski@thermofisher.com, or Investor, Ken Apicerno, +1-781-622-1111, ken.apicerno@thermofisher.com, both of Thermo Fisher Scientific Inc.
Web site: http://www.thermofisher.com/
|
|
|
|
|
|
